EUVIMED · CrossrefZeitschrift
Diabetes Care
ISSN 0149-5992 · American Diabetes Association
Neueste Artikel
Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes
Transient Cognitive Vulnerability After Hypoglycemia in Adults With Type 1 Diabetes: Evidence From Continuous Glucose Monitoring and Cognitive Ecologic Momentary Assessment
Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical Trial
Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study
Fecal Short-Chain Fatty Acids in Young Children and Their Mothers Are Not Associated With Progression to Islet Autoimmunity
Three-Year Glycemic Trajectories in Subgroups With Type 1 Diabetes at Risk for Suboptimal Glycemic Control: A Multicenter Continuous Glucose Monitoring Study
All-Cause Mortality, Morbidity, and Reamputation Rates Following Below-Knee Amputation in 25,176 People With Diabetes: A 25-Year England Population Study
Beyond Traditional Glycemic Measures: CGM Glycemic Profiles Reveal Associations With Cardiometabolic Risk in Individuals Without Diabetes
State-Level Variation in GLP-1 Receptor Agonist Use Among Medicaid Beneficiaries Without Diabetes by State Obesity Coverage Policy
Reactions to Race[ism]: The Relationship Between Differential Treatment Based on Race and Diagnosed Diabetes Status in U.S. Adults
Predictors of Type 2 Diabetes Remission and Relapse After Metabolic-Bariatric Surgery or Medical-Lifestyle Therapy in the ARMMS-T2D Study
Management of Type 2 Diabetes, 2026. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND
Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes
An International Position Statement on Practical Approaches for Inpatient Continuous Glucose Monitoring, Insulin Pumps, and Automated Insulin Delivery Systems in Adults
The Correlation Between Fear and Perceived Frequency of Hypoglycemia and Continuous Glucose Monitoring Metrics in Adults With Type 1 Diabetes Using Diabetes Technology: A 1-Year Analysis
The Association Between Ambient Temperature and Hypoglycemia in People Living With Type 1 Diabetes: A Case Time Series Analysis Using Real-Time Continuous Glucose Monitoring
Subtypes of Type 2 Diabetes and Prediabetes: Mortality and Excess Life Lost in South Asians
Glucose-Derived Personalized HbA1c Correction (GDAC) Study to Improve Alignment Between CGM-Derived Metrics and HbA1c in Different Individuals and Racial Groups With Diabetes: Implications for Clinical Practice
Diabetes Care in 2050: A Human-Centered Road Map From Time in Range to Time in Happiness
Empagliflozin in HNF1A-MODY (MODY3): A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes
Characteristic Traits of Type 1 Diabetes by Age at Presentation Go Over the Rainbow
Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study
White Matter Hyperintensities Moderate the Association Between Diabetes and Non-AD Brain Atrophy
Young-Onset Hypertension Confers Higher Risk of Cardiovascular Disease, Kidney Disease, and All-Cause Mortality in Individuals With Type 2 Diabetes: A Propensity Score–Matched Cohort Analysis
Automated Insulin Delivery Systems in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study
Dose–Response Associations of Intermittent Lifestyle Physical Activity Micropatterns and Incident Type 2 Diabetes
Jahrgänge
2026 · 3522025 · 4342024 · 4092023 · 4352022 · 5322021 · 5032020 · 5822019 · 4702018 · 4912017 · 4082016 · 5082015 · 5162014 · 6732013 · 8862012 · 5802011 · 6812010 · 6702009 · 6422008 · 6292007 · 8162006 · 8022005 · 6662004 · 7292003 · 7952002 · 5812001 · 5072000 · 4541999 · 4861998 · 6061997 · 5131996 · 4111995 · 3801994 · 3431993 · 4321992 · 3911991 · 2781990 · 3171989 · 2051988 · 2361987 · 213
EUVIMED